Literature DB >> 21256284

Simultaneous hybrid revascularization versus off-pump coronary artery bypass for multivessel coronary artery disease.

Shengshou Hu1, Qi Li, Peixian Gao, Hui Xiong, Zhe Zheng, Lihuan Li, Bo Xu, Runlin Gao.   

Abstract

BACKGROUND: This study sought to compare early and midterm clinical outcomes of a simultaneous hybrid coronary revascularization procedure with those in a propensity-matched subset of patients undergoing conventional off-pump coronary artery bypass grafting.
METHODS: From June 2007 through December 2009, 104 consecutive patients (mean age 61.8 ± 10.2 years) with multivessel coronary artery disease underwent elective simultaneous coronary revascularization at Fuwai Hospital. Using propensity score methodology, these patients were matched with 104 patients who had undergone off-pump coronary artery bypass grafting through median sternotomy during the same period. We compared these groups' in-hospital clinical outcomes and freedom from major adverse cardiac or cerebrovascular events at a mean follow-up of 18 ± 7.9 months.
RESULTS: The hybrid procedure required longer operative time and incurred higher in-hospital costs, but had shorter median intubation time (11.6 ± 6.3 vs 13.8 ± 6.8 hours, p = 0.02), intensive care unit length of stay (34.5 ± 35.6 vs 55.3 ± 46.4 hours, p < 0.001), and postoperative in-hospital length of stay (8.2 ± 2.6 vs 9.5 ± 4.5 days, p = 0.01). The hybrid group had significantly less chest tube drainage (789 ± 389 vs 834 ± 285 mL, p = 0.005) and need for blood transfusion (28.8% vs 51.9%, p > 0.001). At a mean follow-up of 18 months, the freedom from major adverse cardiac or cerebrovascular events is in favor of the hybrid group (99.0% vs 90.4%; p = 0.03).
CONCLUSIONS: Compared with conventional off-pump coronary artery bypass grafting, simultaneous hybrid coronary revascularization shortens recovery time and has superior outcomes at a mean follow-up of 18 months. Simultaneous hybrid coronary revascularization provides a safe and reproducible alternative for selected patients with multivessel coronary artery diseases. Copyright Â
© 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21256284     DOI: 10.1016/j.athoracsur.2010.10.020

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

Review 1.  Minimally Invasive Multivessel Coronary Surgery and Hybrid Coronary Revascularization: Can We Routinely Achieve Less Invasive Coronary Surgery?

Authors:  Maria Rodriguez; Marc Ruel
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Jan-Mar

Review 2.  Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease.

Authors:  Ralf E Harskamp; Zhe Zheng; John H Alexander; Judson B Williams; Ying Xian; Michael E Halkos; J Matthew Brennan; Robbert J de Winter; Peter K Smith; Renato D Lopes
Journal:  Ann Thorac Surg       Date:  2013-12       Impact factor: 4.330

3.  Robotic coronary artery bypass grafting decreases 30-day complication rate, length of stay, and acute care facility discharge rate compared with conventional surgery.

Authors:  Galina Leyvi; Stephen J Forest; Vankeepuram S Srinivas; Mark Greenberg; Nan Wang; Alec Mais; Max J Snyder; Joseph J DeRose
Journal:  Innovations (Phila)       Date:  2014 Sep-Oct

Review 4.  A review of hybrid coronary revascularization.

Authors:  Michael Owen Kayatta; Michael Emanuel Halkos
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-11-19

5.  Hybrid myocardial revascularization.

Authors:  Yugal Kishore Mishra; Jatin Yadav
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-03-05

Review 6.  Combining PCI and CABG: the role of hybrid revascularization.

Authors:  Kelly D Green; Donald R Lynch; Tyffany P Chen; David Zhao
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

7.  Hybrid coronary revascularization versus off-pump coronary artery bypass grafting and percutaneous coronary intervention for the treatment of two-vessel coronary artery disease with proximal left anterior descending artery stenosis.

Authors:  Jiapei Qiu; Pengxiong Zhu; Zixiong Liu; Hong Xu; Jun Liu; Qiang Zhao
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

Review 8.  Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: systematic review and meta-analysis.

Authors:  Peng Zhu; Pengyu Zhou; Yong Sun; Yilong Guo; Mingjie Mai; Shaoyi Zheng
Journal:  J Cardiothorac Surg       Date:  2015-05-01       Impact factor: 1.637

9.  Short-term clinical outcomes after hybrid coronary revascularization versus off-pump coronary artery bypass for the treatment of multivessel or left main coronary artery disease: a meta-analysis.

Authors:  Fang-Bin Hu; Lian-Qun Cui
Journal:  Coron Artery Dis       Date:  2015-09       Impact factor: 1.439

10.  Hybrid coronary revascularization as a safe, feasible, and viable alternative to conventional coronary artery bypass grafting: what is the current evidence?

Authors:  Arjan J F P Verhaegh; Ryan E Accord; Leen van Garsse; Jos G Maessen
Journal:  Minim Invasive Surg       Date:  2013-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.